Treatment-Response
Showing 1 - 25 of >10,000
Ischemic Stroke Trial (TS23)
Not yet recruiting
- Ischemic Stroke
- TS23
- (no location specified)
Jul 14, 2023
MDD Trial in Barcelona (Non-invasive transcranial direct current stimulation (tDCS))
Recruiting
- Major Depressive Disorder
- Non-invasive transcranial direct current stimulation (tDCS)
-
Barcelona, SpainGuttmann Barcelona
Jul 6, 2023
Anlotinib Treatment Response Using Contrast Enhanced Ultrasound
Recruiting
- Pheochromocytoma, Metastatic
- +3 more
- Contrast-enhanced ultrasound(CEUS)
-
Beijing, ChinaPeking Union Medical College Hospital
Aug 28, 2023
Pancreatic Cancer Trial in Tampa (Quality fo Life Questionnaire (FHSI), Vioscreen Food Frequency Questionnaire (FFQ),
Recruiting
- Pancreatic Cancer
- Quality fo Life Questionnaire (FHSI)
- +6 more
-
Tampa, FloridaMoffitt Cancer Center
Sep 27, 2023
. Patients Included Will be Those Referred WithPossible
Not yet recruiting
- Asthma
- Biologic Agent
- (no location specified)
Aug 31, 2023
Imaging Parameters and DME Treatment Response
Recruiting
- Diabetic Macular Edema
- Diabetic Retinopathy
- No intervention
-
Durham, North CarolinaDuke Eye Center
Jan 3, 2023
Hepatocellular Carcinoma, Atezolizumab-bevacizumab, Response Evaluation Trial in Seoul (Early response evaluation)
Recruiting
- Hepatocellular Carcinoma
- +2 more
- Early response evaluation
-
Seoul, Korea, Republic ofSeoul National University Hospital
Feb 28, 2023
Atopic Dermatitis Trial in Madrid (Cyclosporin A, Follow-up of Cyclospoin treatment already started)
Recruiting
- Atopic Dermatitis
- Cyclosporin A
- Follow-up of Cyclospoin treatment already started
-
Madrid, SpainHospital La Paz
Jan 11, 2023
Treatment Response Biomarkers in MDD
Recruiting
- Major Depressive Disorder
-
Changsha, Hunan, ChinaCentral South University
Oct 17, 2022
OCD Trial in Belmont (Cognitive bias modification for interpretation bias, Psychoeducation)
Recruiting
- Obsessive-Compulsive Disorder
- Cognitive bias modification for interpretation bias
- Psychoeducation
-
Belmont, MassachusettsMcLean Hospital
Dec 30, 2022
Response and Progression in Glioblastoma
Terminated
- Glioblastoma
- Glioblastoma Multiforme
- MRI
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
Jan 12, 2023
Depressive Disorder Trial in Utrecht (Rivastigmine Transdermal Product, Sham)
Recruiting
- Depressive Disorder
- Rivastigmine Transdermal Product
- Sham
-
Utrecht, NetherlandsUMC Utrecht
Mar 2, 2023
Outcome in Colorectal Liver Metastases
Completed
- The Characteristics of Patients With Colorectal Cancer Liver Metastasis Who Would Benefit More From Bevacizumab
- Deep radiomics-based fusion model
-
Shanghai, ChinaDepartment of General Surgery, Zhongshan Hospital, Fudan Univers
Aug 29, 2023
Cocaine Use Disorder Trial in Pittsburgh (Prize-Based Contingency Management, Treatment As Usual Outpatient Substance Use
Recruiting
- Cocaine Use Disorder
- Prize-Based Contingency Management
- Treatment As Usual Outpatient Substance Use Treatment
-
Pittsburgh, PennsylvaniaVA Pittsburgh Healthcare System University Drive Division, Pitts
Nov 14, 2022
Patient Outcome Assessment Trial (hyperpolarized 13C-labeled pyruvate from dynamic nuclear polarization (DNP) magnetic resonance
Not yet recruiting
- Patient Outcome Assessment
- hyperpolarized 13C-labeled pyruvate from dynamic nuclear polarization (DNP) magnetic resonance spectroscopy
- (no location specified)
Oct 26, 2022
Circulating Tumor Cells for Treatment Response of Lung Cancer
Recruiting
- Lung Neoplasm
- Lung Tumor Resection
-
San Antonio, TexasUT Health San Antonio, M.D. Anderson Cancer Center
Jan 23, 2023
Extracellular Vesicles Obtained by Liquid Biopsy for Neoadjuvant
Recruiting
- Rectal Cancer
- Liquid Biopsy
- Supplementary blood samples collection during the normal follow up of the patients
-
Bordeaux, FranceCHU Bordeaux
Jan 9, 2023
Breast Cancer, Contrast Enhanced Ultrasound Trial in Hershey (Lumason)
Not yet recruiting
- Breast Cancer
- Contrast Enhanced Ultrasound
-
Hershey, PennsylvaniaPenn State Health College of Medicine
Jul 19, 2023
Therapy Using 18F-FSPG PET
Not yet recruiting
- Cancer
- +3 more
- 18F-FSPG PET/CT in NSCLC
- 18F-FSPG PET/CT in HNSCC
- (no location specified)
May 24, 2023
MDD Trial in Atlanta (Ketamine, Placebo)
Recruiting
- Major Depressive Disorder
- Ketamine
- Placebo
-
Atlanta, GeorgiaEmory University
Dec 20, 2022
ADHD Trial in Boston (MRI)
Active, not recruiting
- Attention Deficit Hyperactivity Disorder
- MRI
-
Boston, MassachusettsMassachusetts General Hospital
Sep 22, 2022
Anxiety and OCD
Recruiting
- Obsessive-Compulsive Disorder
- +2 more
- Bergen 4-Day Treatment (B4DT)
-
Bergen, Vestland, NorwayBergen Center for Brain Plasticity
Dec 15, 2022
MDD Trial in Pittsburgh (Escitalopram Pill, Placebo, Levomilnacipran Pill)
Recruiting
- Major Depressive Disorder
- Escitalopram Pill
- +2 more
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh
Dec 1, 2022
Cirrhosis Portal Trial (EUS guided portal pressure gradient measurement)
Not yet recruiting
- Cirrhosis Portal
- EUS guided portal pressure gradient measurement
- (no location specified)
Oct 24, 2022